The University of Chicago Header Logo

Connection

Tamara Vokes to Parathyroid Hormone

Back to Details
This is a "connection" page, showing publications Tamara Vokes has written about Parathyroid Hormone.
Tamara Vokes
Connection Strength
2.870
Parathyroid Hormone
  1. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism. J Clin Endocrinol Metab. 2019 11 01; 104(11):5136-5147.
    View in: PubMed
    Score: 0.570
  2. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. J Clin Endocrinol Metab. 2018 02 01; 103(2):722-731.
    View in: PubMed
    Score: 0.505
  3. rhPTH(1-84) for hypoparathyroidism: a randomized study of patient-reported outcomes. Eur J Endocrinol. 2025 Jul 31; 193(2):310-319.
    View in: PubMed
    Score: 0.212
  4. Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):951-960.
    View in: PubMed
    Score: 0.207
  5. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. J Bone Miner Res. 2023 01; 38(1):14-25.
    View in: PubMed
    Score: 0.176
  6. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism. J Clin Endocrinol Metab. 2022 01 01; 107(1):e372-e385.
    View in: PubMed
    Score: 0.166
  7. Quality of Life in Hypoparathyroidism. Endocrinol Metab Clin North Am. 2018 12; 47(4):855-864.
    View in: PubMed
    Score: 0.132
  8. Quality of life in hypoparathyroidism. Bone. 2019 03; 120:542-547.
    View in: PubMed
    Score: 0.132
  9. Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-µg or 50-µg Daily Doses. Clin Ther. 2017 Oct; 39(10):2096-2102.
    View in: PubMed
    Score: 0.123
  10. Hypoparathyroidism. Nat Rev Dis Primers. 2017 08 31; 3:17055.
    View in: PubMed
    Score: 0.123
  11. Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism. Surgery. 2017 01; 161(1):62-69.
    View in: PubMed
    Score: 0.116
  12. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Endocrine. 2017 Jan; 55(1):273-282.
    View in: PubMed
    Score: 0.115
  13. Ethnic Differences in Osteoporosis After Cardiac Transplantation. J Clin Densitom. 2017 Apr - Jun; 20(2):164-171.
    View in: PubMed
    Score: 0.114
  14. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013 Dec; 1(4):275-83.
    View in: PubMed
    Score: 0.094
  15. Management of Hypoparathyroidism. J Bone Miner Res. 2022 12; 37(12):2663-2677.
    View in: PubMed
    Score: 0.044
  16. The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord. 2021 Nov 20; 21(1):232.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.